NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces Distributions

The NXG Cushing® Midstream Energy Fund (NYSE: SRV) (the “Fund”) declared monthly distributions of $0.45 per common share for each of February, March, April, and May 2026. These monthly distributions will be payable to common shareholders pursuant to the table below: Record Date Ex-Dividend Payment Date Distribution Return of Capital Date Amount Estimate(1) — 2/17/2026 […]

NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces Distributions

NXG NextGen Infrastructure Fund (NYSE: NXG) (the “Fund”) declared monthly distributions of $0.54 per common share for each of February, March, April, and May 2026. These monthly distributions will be payable to common shareholders pursuant to the table below: Record Date Ex-Dividend Payment Date Distribution Return of Capital Date Amount Estimate(1) — 2/17/2026 2/17/2026 2/27/2026

Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months

First ever head-to-head analysis compares overall survival outcomes of ERLEADA® versus darolutamide Retrospective study reinforces real-world efficacy of ERLEADA® for patients with mCSPC Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel experienced a statistically significant 51 percent reduction in the

Vintage Philanthropy: Hollander Foundation Pours $25,000 into Prostate Cancer Research from Wine-Making Proceeds

The Hollander Foundation, dedicated to supporting prostate cancer research, awarded its annual gift to Amy Moran, Ph.D. of the Oregon Health and Sciences University. Dr. Moran’s lab uses a combination of mouse models and tissue cultures to examine how the body’s immune system interacts with an invasive prostate cancer. Dr. Moran uses the most advanced

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced that on January 30, 2025, Edgewise granted inducement stock options to purchase a total of 198,250 shares of Edgewise’s common stock to 7 new non-executive employees in connection

Broadcom Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on Wednesday, March 4, 2026

Broadcom Inc. (NASDAQ: AVGO), a technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its first quarter fiscal year 2026 financial results and business outlook on Wednesday, March 4, 2026 after the close of the market. Broadcom's management will host a conference call at 2:00 p.m. Pacific

Last Call: MSUA Announces Two Week Extension for Mobile Satellite Innovation Award Nominations

10 Award Categories; Nominating Deadline Extended to Feb. 16; Ricky Freeman, President Amazon LEO Government, to Keynote Awards Luncheon The Mobile Satellite Users Association (MSUA), a global not-for-profit focused on amplifying the voice of the millions of users of satellite services for mobile communication, navigation, and safety, is extending the deadline by two weeks for

Schneider Electric Showcases Grid and Transmission Solutions at DTECH® to Help Utilities Maintain Power During Severe Weather and Wildfires

— Introduces major event grid management capabilities featuring advanced prediction, coordination and restoration solutions for utilities — Integrates partner intelligence from Microsoft, AiDASH, Technosylva and Neara to strengthen risk modeling and emergency response — Strengthens transmission and distribution coordination with enhanced software that gives utilities clearer, real-time visibility of their networks and improves decision making

Nexus Agriscience Subsidiary Terpene Belt Farms Selected for UCLA-Led, State-Funded Cannabis Research Grant

Company joins academic-industry research initiative to advance terpene science and support public safety Nexus Agriscience (“Nexus”), a molecular farming company delivering plant-based solutions for flavor, fragrance, and functional ingredient markets, announced today that its subsidiary, Terpene Belt Farms, is participating as the industry research partner in a $1.23 million academic research grant awarded by the

Scroll to Top